KALVISTA PHARMACEUTICALS INC (KALV)
US4834971032 - Common Stock
| MRQ (2024-1-31) | 2023 (2023-4-30) | 2022 (2022-4-30) | 2021 (2021-4-30) | 2020 (2020-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 23.06M | 56.20M | 30.70M | 50.60M | 15.80M | |||
| Marketable Securities | 52.53M | 93.10M | 135.50M | 198.30M | 51.90M | |||
| Receivables | 23.68M | 18.60M | 14.10M | 10.40M | 16.50M | |||
| Other Current Assets | 4.83M | 4.30M | 13.30M | 4.90M | 4.50M | |||
| Total Current Assets | 104.10M | 172.30M | 193.60M | 264.30M | 88.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 9.47M | 10.80M | 10.00M | 7.50M | 3.70M | |||
| Other Non-Current Assets | 397.00K | 100.00K | 200.00K | 200.00K | 200.00K | |||
| Total Non-Current Assets | 9.87M | 10.90M | 10.30M | 7.70M | 3.80M | |||
| TOTAL ASSETS | 113.97M | 183.20M | 203.90M | 272.00M | 92.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 16.03M | 10.20M | 7.90M | 7.80M | 6.00M | |||
| Accounts Payable | 3.10M | 4.80M | 3.60M | 2.00M | 1.70M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 19.13M | 15.00M | 11.60M | 9.80M | 7.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 6.26M | 7.10M | 7.20M | 5.00M | 1.10M | |||
| Total Non-Current Liabilities | 6.26M | 7.20M | 7.20M | 5.00M | 1.10M | |||
| TOTAL LIABILITIES | 25.39M | 22.20M | 18.80M | 14.80M | 8.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -425.08M | -343.10M | -250.20M | -167.80M | -121.60M | |||
| Additional Paid In Capital | 516.92M | 507.10M | 439.10M | 426.40M | 207.20M | |||
| Common Shares | 34.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -3.29M | -3.10M | -3.90M | -1.40M | -1.90M | |||
| Shares Outstanding | 34.60M | 34.20M | 24.60M | 24.40M | 17.80M | |||
| Tangible Book Value per Share | 2.56 | 4.71 | 7.52 | 10.54 | 4.71 | |||
| Total Shareholders' Equity | 88.58M | 161.00M | 185.10M | 257.20M | 83.80M | |||
| TOTAL LIABILITIES AND EQUITY | 113.97M | 183.20M | 203.90M | 272.00M | 92.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 5.44 | 11.49 | 16.69 | 26.97 | 11.52 | |||
| Return On Assets (ROA) | -95.03% | -50.72% | -40.38% | -17.00% | -31.48% | |||
| Return On Equity (ROE) | -122.27% | -57.71% | -44.48% | -17.98% | -34.75% | |||
All data in USD